Rankings
▼
Calendar
GPCR Q4 2023 Earnings — Structure Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
GPCR
Structure Therapeutics Inc.
$3B
Q4 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$31M
Net Income
-$25M
EPS (Diluted)
$-0.54
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$22M
Free Cash Flow
-$23M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$482M
Total Liabilities
$29M
Stockholders' Equity
$453M
Cash & Equivalents
$130M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$31M
-$13M
-139.2%
Net Income
-$25M
-$10M
-136.5%
← FY 2023
All Quarters
Q1 2024 →